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Abstract 
The relationship between intracellular free calcium ([Ca2+] i) and the activation of protein kinase C (PKC) and 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) was investigated in the NSC-19 motoneuron cell line. Increased 
extracellular calcium ([Ca 2+ ]o) up to 10 mM resulted in sustained elevations of [Ca 2+ ]i. Control cell cultures (1.3 mM 
[ Ca2+ ]o, [ Ca2+ ]i = 83 4- 17 nM) contained Ca 2+- and PS/DO lipid-dependent PKC activity predominantly in the cytosol. 
However, elevation of [Ca2+]o up to 5 mM ([Ca2+]~ = 232 + 24 nM) resulted in almost complete loss of cytosolic PKC 
activity. Cells incubated in 10 mM [Ca2+]o ([Ca2+] i = 365 _+ 13 nM) showed increased levels of both cytosolic and 
membrane PKC activity compared to control. These alterations in PKC activity appeared to be translocation-independent, 
since PKC protein levels were unchanged as demonstrated by Western blotting analysis. When cells were exposed to 25 or 
50 mM [Ca 2+ ]o, [Ca 2+ ]i rose transiently to over 600 and 900 nM, respectively, and then returned to near basal values. 
Under these conditions, total PKC activity decreased, and increased amounts of the catalytic fragment of PKC, protein 
kinase M, were generated. Extracts from cells exposed to [Ca 2+ ]o between 1.3 and 25 mM did not differ significantly in the 
levels of measurable CaMKII activity 10 min following the change in [Ca 2+ ]o. 
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1. Introduction 
Recent studies of intracellular calcium concentra- 
tions ([Ca2+]~) in cultured cells have indicated that 
Abbreviations: PKC, protein kinase C; PKM, protein kinase 
M; CaMKII, calcium/calmodulin-dependent protein kinase II; 
Ca 2+, calcium ion; [Ca 2÷ ]i, intracellular f ee calcium concentra- 
tion; [Ca 2÷ ]o, extracellular calcium concentration; EAA, excita- 
tory amino acid; HBSS, Hepes-buffered Hanks' balanced salt 
solution; PMA, phorbol myristate acetate; FBS, heat-inactivated 
fetal bovine serum. 
* Correspondence author. Fax: + 1 604 8227897. 
elevations of [Ca 2+ ]i following excitatory amino acid 
(EAA) application lead to neuronal death. In EAA-in- 
duced cell death, [Ca2+] i rises transiently to a high 
level and returns to approximately basal levels, fol- 
lowed by a late, irreversible [Ca2+]i increase [1-3]. 
Elevated EAA levels have been detected in the cen- 
tral nervous system following cerebral ischemia [4]. 
This suggests that neuron death in ischemia may 
occur by a Ca2+-dependent mechanism similar to that 
observed following EAA application to cultured cells. 
In addition, cell loss in some chronic neurodegenera- 
tive disorders may be a result of long term alterations 
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in cellular Ca 2+ homeostasis [5]. This claim is sup- 
ported by observations of increased Ca 2+ influx in 
neurons exposed to immunoglobulins from patients 
with the neurodegenerative disorder amyotrophic lat- 
eral sclerosis [6]. The elevation of [Ca2+] i, either 
occurring rapidly, such as in cerebral ischemia, or 
slowly, such as in chronic degenerative disorders, is 
believed to produce structural damage to the cells 
through the activation of proteases and protein ki- 
nases and by promoting the formation of free radicals 
[7]. An influx of Ca 2÷ may act as a trigger to activate 
several downstream signalling pathways. A variety of 
studies have suggested roles for the serine/threonine 
kinases, protein kinase C (PKC) and Ca2+/calmodu - 
lin-dependent protein kinase II (CaMKII), in cell 
death following cerebrovascular injury and in chronic 
neurodegenerative disorders [8,9]. 
The role played by PKC in cell death is unclear. 
Furthermore, the relation between alterations in Ca 2 + 
homeostatic mechanisms and PKC activation has not 
been clearly defined. It appears likely that phos- 
phatidylinositol 4,5-bisphosphate hydrolysis is not the 
only mechanism responsible for PKC activation [10- 
12] and that activation of PKC can involve transloca- 
tion of PKC from cytosol to membrane [13], or occur 
independently of membrane translocation [14,15]. 
Proteolysis of PKC can result in the generation of a 
CaZ+-independent kinase, protein kinase M (PKM), 
through cleavage by the Ca2+-activated proteases, 
calpains I and II [16,17]. Previous studies on the 
activation of PKC have not addressed the CaZ+-de - 
pendence of this process and there is controversy as 
to what mechanisms are important for PKC activa- 
tion. Since PKC has been implicated in several cellu- 
lar processes including long-term potentiation, cell 
development, and cell death, it is possible that any of 
these mechanisms of PKC activation might be in- 
volved under different circumstances. 
In this study, we have investigated the effects of 
increased [Ca2+] i in a motoneuron cell line on the 
activation of PKC, CaMKII, and on the conversion of 
PKC to the CaZ+-independent form, PKM. The pur- 
pose of this study was to determine whether modest 
but sustained increases of  [Ca2+]i would result in 
changes in the activity of these kinases and their 
redistribution within cells. Also, we examined 
whether changes in [Ca 2+ ]i would result in the gener- 
ation of PKM from PKC. 
2. Materials and methods 
2.1. Materials 
Fura-2/AM was purchased from Molecular Probes 
(Eugene, OR). Radioactive [T-32p]ATP was obtained 
from Dupont (Mississagua, ON). Antibodies were 
purchased from Upstate Biotechnology (UBI, Lake 
Placid, NY), Transduction Laboratories (Lexington, 
KY), Santa Cruz Biotechnology (Santa Cruz, CA), or 
were obtained as a generous gift from Dr. S. Jaken 
(W. Alton Jones Science Center, Lake Placid, NY). 
Protein kinase A inhibitor peptide (PKIP, amino acids 
5-24) [18,19] and all other reagents were obtained 
either from Sigma (St. Louis, MO) or Fisher Scien- 
tific (Vancouver, BC), unless otherwise stated. Phos- 
phatidylserine (PS) and diolein (DO) lipid stock solu- 
tions were prepared in PKC assay buffer (10 mM 
Mops (pH 7.2), 25 mM /3-glycerophosphate, 0.25 
mM dithiothreitol (DTT), 2 mM EGTA, and 2 mM 
EDTA) after chloroform evaporation. 
2.2. Cell culture 
Monolayer cultures of the motoneuron cell line, 
NSC-19, were used for all experiments. NSC-19 is a 
clonal hybrid cell line derived from the fusion of the 
aminopterin-sensitive neuroblastoma N18TG2 with 
primary dissociated spinal cord cells enriched for 
motoneurons [20]. Spinal cord cells were obtained 
from CD1 mice aged embryonic day 12-14. Unlike 
its neuroblastoma p rent, NSC-19 expresses proper- 
ties observed in motoneurons including: generation of 
action potentials, expression of choline acetyltrans- 
ferase and neurofilament triplet proteins, induction 
and twitching in co-cultured myotubes and synthesis, 
storage and depolarization-evoked r lease of acetyl- 
choline [20]. Cells were grown in 75 cm 2 culture 
flasks until confluent (approx. 6-8 days) in Mini- 
mum Essential Medium (MEM, Stem Cell Technolo- 
gies, Vancouver, BC), supplemented with 10% heat- 
inactivated fetal bovine serum (FBS, Gibco, Grand 
Island, NY) at 5% CO2-95% air at 37°C. Half the 
medium in culture dishes was replaced three times 
weekly. One week prior to calcium imaging experi- 
ments, cells were transferred onto poly-D-lysine 
coated glass coverslips in six well plates (Coming, 
Coming, NY). 
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2.3. Calcium imaging 
NSC-19 cell cultures grown on 25 mm glass cov- 
erslips were studied when almost confluent. Cells 
were transferred to a Hepes-buffered Hanks' bal- 
anced salt solution (HBSS, pH 7.2) containing 137 
mM NaC1, 5.4 mM KC1, 0.16 mM Na2HPO 4, 4.22 
mM NaHCO 3, 0.41 mM MgSO 4, 0.49 mM MgC12, 
20 mM Hepes, 5.5 mM glucose and 1.26 mM CaC12. 
In buffer solutions with higher Ca 2+ concentrations, 
Na + was replaced iso-osmotically for Ca 2+. The pH 
was adjusted with NaOH before the start of each 
experiment. 
[Ca2+] i was measured using the fluorescent Ca 2÷ 
indicator fura-2 acetoxymethyl ester (fura-2/AM), as 
described previously [21]. Briefly, cells were incu- 
bated in 5 /zM fura-2/AM solution for 30 rain at 
room temperature (22°C), washed twice with HBSS 
and allowed to incubate for at least an additional 30 
min in HBSS to ensure complete hydrolysis of the 
fura-2/AM to fura-2. Coverslips containing cells 
loaded with fura-2 were mounted in a perfusion 
chamber with a working volume of 0.2 ml (Warner 
Instrument Corp., CT), and fitted onto the stage of a 
Nikon inverted microscope. Cells were perfused with 
HBSS at 22°C at a flow rate of approx. 1 ml/min. 
Fluorescence measurements were made using a 
Nikon 40 X fluorite (1.3 NA) epifluorescent objec- 
tive fitted to a Nikon Diaphot TMD inverted micro- 
scope, equipped with a 100 Watt xenon light source 
(Osram, Germany). During imaging, light was selec- 
tively filtered at 340 and 380 nm by a computer 
controlled filterwheel. Emitted fluorescence was de- 
tected by a Silicone Intensified Target (SIT) video 
camera (Hamamatsu C2400-08) and fed to an 80386 
based desktop computer, equipped with an image 
detection software package and an analog-to-digital 
video digitizer board (Image-I/F1, Universal Imag- 
ing Corp., PA). Ratios were obtained from 8-frame 
averages at each of 340 nm and 380 nm, once every 5 
s. Ratios were then converted to calcium concentra- 
tions using the method of Grynkiewicz et al. [22]. 
SEM's were calculated for each data point, but were 
only plotted (as error bars) at a few points for clarity. 
Values for Rma x and Fma x (380 nm) were obtained by 
the addition of the Ca 2 +-ionophore 4-bromo-A23187 
(10 /zM, Molecular Probes) to the cells in HBSS 
containing 1.3 mM Ca 2+. Rmi n and Fm~ . (380 nm) were 
obtained by adding EGTA (typically 5 raM) to cells 
in the bath. All measurements were made on single, 
phase-bright cells with evident processes and record- 
ings were made only of cells whose initial baseline 
ratios were stable for at least 3 rain. Each experiment 
was performed at least three times. 
2.4. Preparation of cell extracts 
NSC-19 cells were grown in MEM with 10% FBS 
for a period of 7-10 days or until confluent. Cells 
were washed once in phosphate buffered saline (PBS) 
for 1 min and then treated in HBSS containing 
var ious  Ca  2+ concentrations at room temperature. 
HBSS was then replaced with 3 ml ice-cold lysis 
buffer containing: 10 mM MOPS (pH 7.2), 25 mM 
/3-glycerophosphate, 2 mM EGTA, 2 mM EDTA, 
0.25 mM DTT, 1 /xg/ml leupeptin, 1 /zg/ml pep- 
statin, 1 mM PMSF, and 1 mM benzamidine. Each 
treatment was performed in triplicate in 75 cm 2 flasks 
and the cell cultures were pooled into 1.5 ml Eppen- 
dorf microcentrifuge tubes, on ice, and centrifuged at 
1000 rpm (Biofuge) for 5 rain at 4°C. The lysis buffer 
was then aspirated and replaced with 0.6 ml of fresh 
ice-cold buffer. Cells were then sonicated for 6 s, 3 
times (at the 40 setting of a Sonics Vibra-Cell) on ice 
and clarified by centrifugation (10000 X g, 15 rain) 
at 4°C. The supernatant was then subjected to further 
centrifugation (200000 × g, 25 min) at 4°C in a 
Beckman TL-100 ultracentrifuge and the cytosolic 
cell extract (supernatant) was immediately aliquoted 
and stored at -70°C. The pellet was sonicated as 
before in 0.5 ml of lysis buffer containing 1% Triton 
X-100. The detergent-solubilized (membrane) xtract 
was obtained after ultracentrifugation (200000 X g, 
25 min, 4°C) and was also aliquoted and stored at 
-70°C. Protein content was estimated by the method 
of Bradford [23] with bovine serum albumin (BSA, 
Sigma) as the standard. Extracts were rapidly thawed 
and 0.8 mg of cytosolic or Triton X-100 solubilized 
membrane extracts were fractionated on a l-ml 
MonoQ 5/5  anion exchange column (Pharmacia, 
Baie d'Urfe, PQ). Fractions (0.25 ml) were eluted at 
a flow rate of 0.8 ml/min using a linear gradient of 
0-0.8 M NaC1 in 10 ml of buffer containing: 10 mM 
MOPS (pH 7.2), 2 mM EGTA, 5 mM EDTA, 2 mM 
Na3VO4, 25 mM /3-glycerophosphate, and 0.25 mM 
DTT. 
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2.5. Protein kinase C assays 
The crude extracts and MonoQ column fractions 
were assayed for the presence of PKC and PKM 
activity by measuring the extent of 32p transfer from 
[T-32p]ATP to histone H1 (Sigma IllS). Column 
fractions or crude extracts (5 /.tl) were assayed for 10 
min at 30°C in an assay tube (final volume of 25.5 
/~1) which contained: histone H1 (1 mg/ml),  50 /zM 
[T-32p]ATP (1250 cpm/pmol), 10 mM MOPS (pH 
7.2), 2 mM EDTA, 2 n~1 EGTA, 25 mM /3-glycero- 
phosphate, 10 mM MgC12, 1 mM Na3VO4, 0.25 mM 
DTT, and 0.5 /xM cAMP-dependent protein kinase 
inhibitor peptide (PKIP). Where indicated, the incu- 
bations also included: phosphatidylserine (PS, 60 
/zg/ml), diolein (DO, 6/zg/ml) ,  and 4.5 mM CaC12 
(estimated at a free Ca 2÷ concentration of 0.8 mM 
[24]). Reactions were terminated by spotting a 20 /zl 
aliquot of the reaction mixture onto 2 × 2 cm pieces 
of Whatman P81 phosphocellulose paper which were 
dried for 30 s, and washed several times with 1% 
(v/v) orthophosphoric a id. The filter papers were 
then transferred to scintillation vials with 0.5 ml of 
Ecolume (ICN, Mississagua, ON) scintillation fluid 
and analyzed for radioactivity using a Beckman 
LS5000 scintillation counter. Each experiment was 
performed at least three times using cultures of com- 
parable passage number. For activity assays of PKC 
and CaMKII, statistical comparisons were made be- 
tween groups and controls using an analysis of vari- 
ance (ANOVA) with Tukey's and Dunnett's compar- 
ison 
2.6. Calcium / calmodulin-dependent protein kinase 
H assays 
The activity of CaMKII was determined by mea- 
suring the extent of phosphorylat ion of 
CaMKIIc~[281-291] peptide (MHRQETVDCLK, 
Calbiochem, La Jolla, CA) in the crude and MonoQ 
fractionated cytosolic extracts. This peptide is a selec- 
tive substrate for CaMKII and bears the consensus 
sequence Arg-X-Y-Ser(Thr) which allows for phos- 
phorylation catalyzed by CaMKII [25]. Reactions us- 
ing 20/zg protein were carried out for 30 s at 30°C in 
mixtures containing: CaMKIIo~[281-291] (0.67 
mg/ml),  50 /.~M ['y-32p]ATP, 50 mM Hepes (pH 
7.4), 10 mM MgC12, and 0.25 mM DTT in a final 
volume of 30 /xl. As well, incubations included 0.7 
mM CaC12 and calmodulin (UBI, 0.02 mg/ml) where 
indicated. Reactions were terminated by spotting 25 
~1 of the mixtures onto P81 paper and the radioactiv- 
ity was determined by scintillation counting as for the 
PKC assays. 
2.7. In vivo phosphorylation and immunoprecipita- 
tion 
NSC-19 cells were maintained in MEM with 10% 
FBS and washed with phosphate-free MEM prior to 
cell labelling. Phosphate labelling was carried out in 
phosphate-free MEM supplemented with 10% FBS 
and [ 32p]_inorganic phosphate (32 Pi, 0.15 mCi/ml) 
for 24 hr in 5% CO 2 at 37°C. Cells labelled with 32p~ 
were rinsed with PBS for 1 min and exposed to 
HBSS containing a [Ca2+] o of 1.3 or 10 mM for 10 
min. The HBSS was replaced with ice cold lysis 
buffer as described above. Cells were then scraped 
and resuspended in fresh lysis buffer containing 2% 
SDS, and passed through a 25 gauge needle. Any 
remaining DNA in the extracts was shredded by 
spinning extracts through a QIAShredder homoge- 
nizer (Qiagen, Chatsworth, CA). PKC and CaMKII 
were immunoprecipitated with anti-PKC a, /3 (Dr. 
S. Jaken) and anti-CaMKlI (Transduction Laborato- 
ries) antibodies, respectively. Briefly, NETF buffer 
[3% Nonidet P40, 100 mM NaC1, 5 mM EDTA, 500 
mM Tris-HC1 (pH 7.4), 50 mM NaF, and 1 mM 
PMSF] was added to the extracts along with the 
anti-PKC or anti-CaMKII antibodies. Following a 6 h 
incubation at 4°C, protein A Sepharose (Pharmacia) 
was added and the mixture was incubated for an 
additional 2 h at 4°C. Immunoprecipitated PKC or 
CaMKII, bound to protein A Sepharose beads was 
spun and analyzed by SDS-PAGE on 11% gels. 
Immunoprecipitated proteins were then transferred to 
PVDF (Dupont) membranes and exposed to auto- 
radiography film (Dupont) to visualise the 32p_ 
labelled proteins. Films were scanned into TIFF for- 
mat images (Abaton Scan 300). 
2.8. Immunoblot analysis 
Crude extracts or MonoQ fractions were resolved 
by SDS-PAGE on 11% gels. Proteins were then 
transferred to nitrocellulose membranes and probed 
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for the presence of PKC and PKM using anti- 500 
PKC/PKM antibodies, and for the presence of 
400, 
CaMKII using anti-CaMKII antibodies. Visualization 
on autoradiography film was performed using en- a00- 
hanced chemiluminescence (Amersham, Oakville, % 
ON) following incubation with horseradish peroxi- 2oo. 
dase (HRP)-conjugated anti-rabbit (1:5000) or anti- 
mouse (1:3000) IgG (Transduction Laboratories). 100. 
Films were then scanned into TIFF format and band 
0 densities were quantified using the NIH Image pro- 
gram. A mixture of ce-, /3-, and T-PKC was purified 
from rat brain as described elsewhere [26] and used 1200 
as a positive control for anti-PKC antibody speci- 
ficity. Positive controls for CaMKII were obtained 1000 
from Transduction Laboratories. 
3. Results 
3.1. Effect of changing extracellular Ca 2+ concen- 
tration on [Ca 2 + ]i 
[Ca2+]i values were obtained using a 5 /~M fura- 
2 /AM loading solution as this fluorochrome concen- 
tration allowed cells to load without evidence of dye 
compartmentalization. The basal [Ca2+]i of cells in 
HBSS containing 1.3 mM Ca 2+ approximated a nor- 
mal distribution with a mean [Ca2+] i of 83 _ 17 nM 
(mean ___ SD, n = 506 cells). Changing the extracellu- 
lar calcium concentrat ion ([Ca2+]o) resulted in a 
change in [Ca2+]i (Fig. 1). When [Ca2+]o was ele- 
vated from 1.3 to 2.5 mM, [Ca2+] i rose to a steady 
state value of 140_+ 8 nM (Fig. 1A) which was 
maintained for at least 10 min. Changing [Ca2+] o
from 1.3 mM to 5 mM and 10 mM also resulted in 
sustained increases in [Ca2+]i to 232 + 24 nM and 
365 _+ 13 nM, respectively, after 10 min following 
the change in [Ca2+]o . When NSC-19 cells were 
exposed to HBSS containing 25 mM and 50 mM 
Ca 2+ (Fig. 1B), [Ca2+] i rose transiently within 2,5 
min to values greater than 600 nM and 900 nM, 
respect ively.  [Ca 2+ ]i then returned to around 202 + 14 
nM and 122 _+ 6 nM, respectively, and reached those 
levels at 10 min following the change in [Ca 2+ ]o. The 
transient nature of the profiles observed with 25 mM 
" ~ +  
and 50 mM [Ca" ]o, compared with the steady in- 
crease after exposure to 2.5 mM, or 5 mM and 10 
mM [Ca2+]°, indicated that different mechanisms 
T__ ~ 'T 1 0.0 mM4 n. = 31 
/ ~ T T  _7  ~ ' n - 3 4  
' i , i ' i , [ , i • [ , i , i ' i ' [ , i • 




% 4oo o 
2O0 
0 1 : 
T 
25.0 raM, n = 51 
50.0 mM, n = 47 
3 4 5 6 7 8 9 10 11 
Time (min) 
Fig. 1. Effect of [Ca 2+ ]o on [Ca 2+ ]i- Cells initially in HBSS 
containing 1.3 mM Ca 2+ were exposed to buffers with 2.5 mM, 
5 mM, or 10 mM [Ca 2+ ]o (A) or 25 mM or 50 mM [Ca 2+ ]o (B) 
in separate xperiments. Traces show mean values for [Ca 2÷ ]~ 
and error bars indicate SEM for given mean values. For clarity, 
error bars are shown at only a few points. 
likely mediate the changes in lEa 2+ ]i in NSC-19 cells 
depending on [Ca 2÷ ]o. Since NSC-19 cells are able to 
maintain reproducible levels of free [Ca2+] i upon 
exposure to different levels of [Ca2÷]o, we investi- 
gated the effect of the different [Ca2+]~ on the activa- 
tion of the calcium-activated kinases CaMKII and 
PKC. 
3.2. Effect of [Cae + ] i on CaMKII 
To determine if changes in [Ca2+] i resulted in 
altered CaMKII activity, crude and MonoQ fraction- 
ated cytosolic extracts from cells exposed to buffers 
containing 1.3, 2.5, 5, 10, 25, and 50 mM Ca 2+ were 
assayed for CaMKII activity as described in Section 
2.6. After exposure of the cultures to the buffers for 
10 min, NSC-19 cell extracts were prepared and 
separated into soluble (cytosolic) and particulate 
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(membrane) fractions by ultracentrifugation. Extracts 
were then subjected to MonoQ anion exchange chro- 
matography. Fig. 2 shows a representative profile of 
CaMKII activity elution of control cytosolic protein 
from MonoQ using the CaMKIIc~ [281-291] peptide 
as substrate. The peak CaMKII  activity coincides 
with CaMKII  immunoreactivity of these fractions, 
detected by immunoblot analysis using anti-CaMKII 
antibodies. As well, the salt concentration at which 
the peak CaMKII  activity eluted is consistent with 
the elution characteristics for CaMKII  described else- 
where [25,27]. Incubation of NSC-19 cells in [Ca2+] o
up to at least 25 mM did not significantly alter the 
activity of cytosolic CaMKII, the extent of CaZ+-in - 
dependence of the kinase (Fig. 3A), or the levels of 
immunoreactive CaMKII  protein (Fig. 3B). Phos- 
phate labelling of NSC-19 cells, followed by expo- 
sure to 1.3 or 10 mM [Ca2+]o and immunoprecipita- 
tion with anti-CaMKII antibodies, revealed no change 
in the amount of CaMKII  phosphorylation with 10 
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Fig. 2. MonoQ (fast protein liquid) chromatography (FPLC) 
profile of cytosolic fractions of NSC-19 cells under control 
conditions. Cytosolic protein (0.8 mg) was loaded onto a 1-ml 
MonoQ 5/5 column (Pharmacia) nd eluted with a 10-ml inear 
gradient of 0-0.8 M NaC1 in MonoQ buffer as described. The 
0.25-ml column fractions were assayed for phosphotransferase 
activity toward CaMKIIa[281-291] in the presence of CaC12, 
and calmodulin. Aliquots (150 /xl) of fractions (#23-33 shown) 
were also subjected to SDS-PAGE electrophoresis and probed for 
CaMKII using anti-CaMKII antibodies (Transduction Laborato- 
ries), following transfer to nitrocellulose (inset). Profile is repre- 
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Fig. 3. (A) Effect of [Ca 2+ ]o on activation of CaMKII. NSC-19 
cells were exposed to buffers with different [Ca 2+ ]o for 10 rain 
prior to harvesting. Cytosolic extracts were assayed for CaMKII 
activity in the presence of Ca 2+ and calmodulin (open bars), or 
in the absence of these activators (with EGTA, hatched bars). 
Values are the means + S.D. of at least hree independent experi- 
ments for each [Ca 2+ ]o. (B) Western immunoblot analysis of 
crude soluble fractions from NSC-19 cells exposed to different 
[ Ca2+ ]o for 10 min. Aliquots containing 150 /xg of protein were 
separated by SDS-PAGE and transferred to nitrocellulose. Anti- 
CaMKII antibodies (Transduction Laboratories) were used to 
determine the levels of CaMKII protein. The [Ca 2+ ]o (mM) at 
which cells were incubated is shown above the lanes, (C) Autora- 
diograph of immunoprecipitated CaMKII protein following in 
vivo labelling and exposure to 1.3 or 10 mM [Ca 2+ ]o- Lane 
marked ( - )  indicates antibody alone. 
3.3. Effect of lCa 2 + ]i on PKC 
To determine whether the steady or transient in- 
creases in [Ca 2+ ]i altered the activity of PKC, histone 
H1 phosphorylation assays were performed with ex- 
tracts from cells that had been exposed for l0 min to 
buffers containing 1.3, 2.5, 5, 10, 25 and 50 mM 
Ca 2+. MonoQ column fractions of cell extracts were 
assayed for histone H1 phosphotransferase activity in 
the presence of Ca 2÷, PS, and DO, or without these 
PKC activators as described in Section 2.5. Fig. 4 
shows representative MonoQ profiles of cytosolic 
and membrane fractions of NSC-19 cell extracts ex- 
posed to 1.3, 10, and 50 mM [Ca2+]o, respectively. 
These profiles demonstrate he presence of two activ- 
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Fig. 4. MonoQ FPLC profile of cytosolic (panels A-C)  and Triton X-100-solubilized membrane (panels D-F) fractions of NSC-19 cells 
exposed for 10 min to 1.3 mM (A, D), 10 mM (B, E), or 50 mM (C, F) Ca2+-containing HBSS. Cytosolic and membrane extracts (0.8 
mg) were loaded separately onto a 1-ml MonoQ 5/5  column and eluted with a 10-ml linear gradient of 0-0.8 M NaC1 in MonoQ buffer 
(dashed lines) as described in Section 2.4. The 0.25-ml column fractions were assayed for phosphotransferase ctivity toward histone H1 
in the presence of CaC12, and PS/DO lipid (closed symbols) or in the absence of these PKC activators (open symbols). Each profile is 
representative of data obtained in at least three separate xperiments. 
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Fig. 5. Western immunoblot f peaks I and II from MonoQ profiles obtained from cytosolic extracts of NSC-19 cells incubated in 50 mM 
[ Ca2+ ]o for 10 min. Column fractions were subjected to SDS-PAGE and transferred to nitrocellulose. Immunoblotting was performed 
with anti-PKC a, /3 monoclonal antibodies (Dr. S. Jaken), or anti-pan specific PKC/PKM polyclonal antibodies (UBI). Similar results 
were obtained in at least 3 immunoblots employing a variety of monoclonal nd polyclonal anti-PKC/PKM antibodies: anti-PKC a (Dr. 
S. Jaken, Gibco, Transduction Laboratories, Santa Cruz), anti-PKC a, /3 (Dr. S. Jaken), anti-PKC /3's (Gibco, Transduction 
Laboratories), anti-PKC y (Gibco, Transduction Laboratories, Santa Cruz), anti-Pan specific PKC (Santa Cruz, UBI). A mixture of 
purified rat brain a-, /3-, and T-PKC isoforms was used as positive control (not shown). 
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ity peaks (Peaks I and II), which eluted at approx. 0.3 
M and 0.5 M NaC1. Peak I phosphorylating activity 
was determined to be dependent upon both Ca 2÷ and 
PS/DO lipid in separate xperiments (not shown), 
and is indicated in Fig. 4 by the differences between 
the profiles with Ca 2+ and PS/DO (closed symbols) 
and without activator (with EGTA, open symbols). 
Peak II activity was independent of Ca 2÷ and PS/DO. 
The elution position and activator dependencies of
Peak I was consistent with PKC as demonstrated 
elsewhere [14,28-30]. A component of Peak II activ- 
ity was attributable to PKM as previously described. 
The identification of the kinases in the two peaks was 
further supported by immunoblot analysis of the 
MonoQ fractions using antibodies pecific for the 
PKC a, /3, and 3' isoforms, as well as using anti-pan 
specific PKC/PKM antibodies. As shown in Fig. 5, 
fractions 23-25 following MonoQ chromatography 
demonstrated an ~ 80 kDa band (PKC), and frac- 
tions 34-38 contained ~ 45 kDa bands correspond- 
ing to PKM [31]. Moreover, Ro 31-8220 (400 nM, 
compound 3, Calbiochem) and a peptide (RFARK- 
GALRQKNV, 100 /~M) based upon the pseudosub- 
strate inhibitory sequence in PKC [32,33] were both 
potent and specific inhibitors of the Peak I phospho- 
rylating activity (90% and 85%, respectively, data not 
shown). 
The activities of PKC and PKM at each [cae+] o 
were determined by measuring the areas under peaks 
I and II, respectively, in MonoQ profiles determined 
by histone H1 kinase activity assays, and correcting 
for the protein amounts obtained in the cytosolic and 
particulate xtracts. As shown in Fig. 6A, when 
NSC-19 cells were exposed to 2.5 mM [Ca2÷] o for 
10 min, cytosolic PKC activity decreased to approx. 
60% of control values. In addition, membrane-associ- 
ated PKC activity increased approx, five-fold, consis- 
tent with the notion that cytosolic PKC had partially 
translocated to the membrane. Changing [Ca 2 ÷ ]o from 
1.3 mM to 5 mM for 10 min resulted in an almost 
complete loss of cytosolic PKC activity with a corre- 
sponding five-fold increase in membrane-associated 
activity. Based upon phosphotransferase ctivity mea- 
surements, PKC apparently completely translocated 
to the membrane at a [Ca2+] i of approx. 250 nM 
([cae+]o=5 raM). However, subsequent immuno- 
blotting studies with monoclonal anti-PKC a, /3 and 
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Fig. 6. Effect of [Ca2+]o on activation of PKC. NSC-19 cells were exposed to buffers with different [Ca2+] o for 10 min prior to 
harvesting. Extracts containing 0.8-rag protein were loaded onto a l-ml MonoQ column and 0.25-ml fractions were collected as described 
in Section 2. Areas under the histone H1 phosphorylating MonoQ profiles were determined and plotted as (A) Peak I: area of regions 
under peak I in the presence of Ca 2+, PS, and DO (after subtraction of activities obtained in the absence of activators), and (B) Peak II: 
area of regions under peak II in the absence of activators. Values are the means _+ S.D. of at least three independent experiments for each 
[Ca2+]o . In several groups, S.D. values were too small to be distinguished from the means. Asterisks indicate groups which are 
significantly different (P  < 0.01) from control (1.3 mM [Ca 2+ ]o). 
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tion for the activity changes was incorrect as PKC 
protein levels were unchanged (Fig. 7A). 
Cells studied after 10 min incubation in 7.5 mM 
[Ca2+] o demonstrated levels of membrane-associated 
PKC activity comparable to cells at 5 mM [Ca2+]o 
(Fig. 6A). In addition, there was an increased level of 
PKC activity in the cytosolic fractions which ex- 
ceeded that detected under unstimulated conditions. 
With 10 mM [Ca 2+ ]o, PKC activity was greater than 
that observed at 7.5 mM in both membrane and 
cytosol fractions. However, the increased activity 
observed at 10 mM [Ca 2+ ]o was not accounted for by 
an increase in the amount of PKC protein (Fig. 7A) 
when blots were probed for PKC a, /3 or y, suggest- 
ing that the specific activity of PKC was increased 
when [Ca2+] i was elevated to approx. 350 nM 
([Ca2+]o = 10 mM). 
The in vivo phosphorylation of PKC was per- 
formed to determine if increased phosphorylation of
PKC was evident when NSC-19 cells were incubated 
at [Ca2+]o of l0 mM compared to control. Phosphate 
labelling of these cells revealed that in NSC-19 cells 
proteins were phosphorylated both at [Ca2+] o of 10 
mM and at control (1.3 mM) levels. Phosphorylation 
of immunoprecipitated PKC protein was much more 
extensive under the high [Ca 2+ ]o (10 mM) conditions 
compared to control (Fig. 7C). However, this in- 
creased phosphorylation at 10 mM was not accompa- 
nied by a change in immunoreactive PKC protein as 
determined by immunoblotting. 
At a [Ca2+] o of 25 mM, cytosolic PKC activity 
decreased by approx. 80% compared to control, with 
no change in membrane-associated PKC activity (Fig. 
6A). Exposure to buffer containing 50 mM Ca 2+, 
resulted in decreased PKC activity in both cytosol 
and membrane fractions to approx. 12% and 36% of 
control values, respectively. These levels of PKC 
activity were substantially lower than those observed 
at I0 mM [Ca2+]o . The decrease in PKC activity at 
these levels of [Ca2+] o indicated that PKC was sub- 
jected to proteolysis by calpain. As the proteolysis of 
PKC is believed to be mediated by calpain, in some 
experiments cells were pre-treated with calpeptin (1 
/zM, Calbiochem), an inhibitor of calpains I and II, 
for 18 hr prior to exposure to [Ca 2+]o of 25 mM. 
Following pre-treatment of cells with calpeptin, cy- 
tosolic PKC activities in cells exposed to 25 mM 
[ Ca2 + ]o increased by approx. 2-fold (665 _+ 120 
pmol/min from 292 _+ 65 pmol/min, data not 
shown). 
The level of Peak II histone H 1 phosphotransferase 
activity (Fig. 6B) did not change significantly when 
A Cytosolic Fractions Membrane Fractions 
(+) 1.3 2.5 5 10 25 50 1.3 2.5 5 10 25 50 
PKC c~,13 97 kDa 
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PKC y kDa 
Soluble Extracts C 1.3 10 (-) 




Fig. 7. (A) Western immunoblot fcrude soluble and particulate fractions from NSC-19 cells exposed to different [Ca 2+ ]o for 10 min. 
Aliquots containing 150 /zg of protein were loaded onto each well and transferred to nitrocellulose following SDS-PAGE. Anti-PKC a, 
/3 (Dr. S. Jaken), or anti-PKC y (Santa Cruz) antibodies were used to determine the levels of PKC protein. The [Ca 2+ ]o (mM) at which 
cells were incubated is shown above the lanes. A mixture of native a-, /3-, and y-PKC was used as positive control (+). (B) Western 
immunoblot fcrude cytosolic extracts of NSC-19 neurons probed for PKM with anti-pan specific PKC/PKM antibodies (UBI). Similar 
results for each of (A) and (B) were obtained in at least 3 immunoblots u ing antibodies from several sources. Visualization was 
performed by ECL as described in Section 2.8. (C) Autoradiograph of immunoprecipitated PKC protein following in vivo labelling and 
exposure to 1.3 or 10 mM [Ca2+] o.Lane marked ( - )  indicates antibody alone. 
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[Ca2+]o was changed from 1.3 mM to 2.5, 5, 7.5 or 
10 mM for 10 min. At 25 mM and 50 mM [Ca2+]o, 
the Peak II kinase activity in the cytosolic fractions 
for both groups increased up to eight-fold. Similarly, 
membrane-associated Peak II kinase activity in- 
creased by ten-fold over controls. Part of the Peak II 
activity was distinct from PKM as it was not inhib- 
ited by either the pseudo-substrate p ptide or Ro 
31-8220. The decrease in PKC activity and corre- 
sponding increase in Peak II kinase activity at 25 and 
50 mM supports the possibility that PKC was proteo- 
lytically cleaved to PKM, likely through the actions 
of calpain [16,17,34]. Consistent with this notion was 
the increase in PKM protein levels seen after expo- 
sure of cells to 25 mM Ca 2÷ (Fig. 7B), detected with 
anti-Pan specific PKC/PKM antibodies. Incubation 
of cells to 2.5, 5 or 10 mM [Ca2+]o did not reveal 
any changes in immunoreactive PKM protein levels 
over control. However, in extracts from cells exposed 
for 10 min to 25 mM [Ca2+] o, PKM levels were 
higher than in control extracts, indicating that PKM 
was generated from PKC. 
To confirm that the PKC antibody reagents em- 
ployed in this study were capable of detecting 
translocations of Ca2+-activated PKC isoforms from 
the cytosol to membrane fractions of NSC-19 cells, 
these cells were treated with phorbol myristate ac- 
etate (PMA, 100 nM, 5 min). The activity of PKC in 
the cytosol and membrane fractions were then com- 
pared to the immunoreactive PKC levels. PMA treat- 
ment caused a 60% decrease in cytosolic PKC activ- 
ity and a corresponding four-fold increase in mem- 
brane-associated PKC activity as demonstrated by the 
MonoQ profiles shown in Fig. 8. These changes in 
cytosolic and membrane-associated PKC activity were 
reflected by a corresponding translocation of im- 
munoreactive PKC protein levels from the cytosol to 
the membrane, as detected in crude extracts by anti- 
PKC c~, /3 monoclonal antibodies. Therefore, the 
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Fig. 8. MonoQ FPLC (A) and Western immunoblot (B) of cytosol and membrane fractions from untreated NSC-19 cells (control [7, I )  
or cells treated for 5 min with 100 nM phorbol myristate acetate (PMA, C), O). Closed symbols in MonoQ profiles indicate histone HI 
phosphotransferase activity in the presence of Ca 2+, and PS/DO lipid. Open symbols indicate activity in the absence of the PKC 
activators. Dashed lines indicate the NaCI concentration f the elution buffer. Anti-PKC a, /3 antibodies (Dr. S. Jaken) were used for 
PKC protein detection by ECL. A mixture of native c~-, /3-, and 7-PKC was used as positive control (PKC c~, /3, ~/). 
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PKC shown in Figs. 4 and 6 could not be ascribed to 
a redistribution of PKC within the cell. 
4. Discussion 
The mean resting [Ca2+] i of NSC-19 cells was 
similar to previously published values for this cell 
line [21] and for other neuronal cells [3,35,36]. [Ca 2+ ]i 
in these cells was found to be dependent on [Ca2+] o
as has been observed previously for mammalian thy- 
mocytes [37], keratinocytes [38], and rat cortical neu- 
rons [39]. These variations in [Ca 2+ ]i with changes in 
[ Ca2+ ]o are likely the result of transmembrane move- 
ment of Ca 2+ through CaZ+-leak channels [40], the 
CaZ+-ATPase [41], and/or  the Na+/Ca 2+ exchanger 
[42]. 
When NSC-19 cells were exposed to buffers con- 
taining 2.5-10 mM Ca 2+, [Ca 2+]i increased steadily 
to levels which were maintained for at least 10 min 
(Fig. 1). In contrast, changing [Ca2+]o from 1.3 mM 
to 25 or 50 mM resulted in large, transient increases 
in [Ca 2+ ]i which then returned to values that approxi- 
mated the steady state [Ca2+] i obtained with 5 mM 
and 2.5 mM [Ca2+] o, respectively. It is possible that 
exposure of cells to 25 mM and 50 mM [Ca2+]o 
resulted in the activation of Ca 2 + extrusion or buffer- 
ing processes which are not activated when the cells 
are exposed to lower [Ca2+] o. The mechanisms of 
Ca 2+ extrusion or buffering were not investigated 
further in this study. The large transient Ca 2+ re- 
sponses observed following exposure to 25 and 50 
mM Ca 2+, may also have resulted in the activation of 
some Ca2+-dependent processes which require high 
levels of [Ca2+] i for activation and were not seen 
with exposure to lower [Ca2+] o. 
Changes in [Ca2+] i did not alter the activity or 
CaZ+-dependence of CaMKII in these cells, at 10 min 
following the change in [Ca2+]i . It is likely that 
CaMKII activity was modified by [Ca2+] o but may 
have returned to baseline by the time measurements 
were made at 10 min following the stimulus. In 
cultured cortical neurons, CaMKII activity reaches 
90% of maximum after 10 s of synaptic activation. 
Following blockade of synaptic stimulation, CaMKII 
activation falls by 50% in 10-30 s [43]. It is also 
possible that elevated [Ca2+]i generated by changes 
in [Ca 2+ ]o are a poor stimulus for CaMKII activation. 
In cultured hippocampal neurons, activation of volt- 
age-dependent Ca2+ channels by KC1 does not alter 
CaMKII activity whereas glutamate xposure has 
profound effects on CaMKII [44]. CaMKII activity 
was studied at 10 min following the change in [Ca 2÷ ]o 
to evaluate its contribution to changes in histone H1 
phosphotransferase activity. The substrate used, 
CaMKIIa [281-291] peptide, bears the consensus 
sequence for CaMKII and is not phosphorylated by 
some other Ca2+/calmodulin-dependent kinases 
[45,46]. The level of CaMKII phosphorylation and 
immunoreactive CaMKII protein also appears to be 
unaffected by changes in [Ca2+]i in NSC-19 cells at 
10 min, consistent with the CaMKII activity profile. 
In contrast to the lack of change in CaMKII activ- 
ity, there were marked changes in the phosphotrans- 
ferase activity of PKC with the elevation of [Ca 2+ ]i. 
The decrease in cytosolic PKC activity and corre- 
sponding increase in PKC activity in the membrane 
fraction with changes in [Ca2+]o from 1.3 mM up to 
5 mM seemed to indicate that PKC translocates to the 
membrane in response to a rise in [Ca2+] i from 80 
nM to 250 nM. However, this was not substantiated 
by immunoblotting analysis. The lack of a correlation 
between activity and protein levels was not due to a 
lack of sensitivity of the anti-PKC antibodies, since 
redistribution of PKC protein could be detected after 
phorbol ester treatment of NSC-19 cells (Fig. 8). The 
Ca 2+- and PS/DO lipid-dependence of the PKC 
activity and its sensitivity to inhibition by the pseudo- 
substrate inhibitory domain peptides for the calcium- 
activated forms of PKC demonstrated that it arose 
from one or more of the a, /3, and y isoforms, and 
these were clearly visualized by the various PKC 
antibodies used. 
With incubation at [Ca 2+ ]o values of 7.5 mM and 
10 mM corresponding to a [Ca2+]i of about 350 nM, 
PKC activity increased in both cytosol and membrane 
fractions. Again, PKC protein levels were unchanged. 
It is possible that the increased PKC activity with 
7.5-10 mM [Ca2+] o was due to the activation of a 
previously inactive pool of PKC which required a 
threshold level of [Ca 2+ ]i for its activation. 
Similar increases in cytosolic and particulate-de- 
rived PKC activities have been observed for rabbit 
platelets exposed to platelet-activating factor (PAF) 
or PMA [14,29,30], for the mast cell/megakaryocyte 
cell line R6-XE.4 activated by IL-3 [28], and for 
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human T lymphocytes exposed to phytohemagglu- 
tinin [47]. However, the [Ca2+]i n these experiments 
was not investigated, and the kinetics of the PKC 
activations were different from what we observed. 
Pelech et al. [30] suggested that the apparent translo- 
cation-independent i creases in PKC activity seen 
following PAF stimulation of platelets may be due to 
the phosphorylation f PKC either through autophos- 
phorylation or by another kinase. To explore the 
mechanism for the increase in PKC specific activity 
at 10 mM [Ca 2+ ]o, we performed in vivo phosphory- 
lation experiments. These experiments demonstrated 
that PKC was much more extensively phosphorylated 
when [Ca2+]o was 10 mM, than under control condi- 
tions. Although it is not clear whether or not the 
increased phosphorylation is due to autophosphoryla- 
tion or phosphorylation by some other kinase, it is 
possible that the increased specific activity observed 
in the present study is related to the increased phos- 
phorylation of PKC. Our observations at 10 mM 
[ Ca2+]o are consistent with covalent modification of 
PKC as immunoblot analysis of crude extracts (Fig. 
7) did not reveal increased PKC protein in either 
cytosolic or membrane fractions compared to con- 
trols. As well, the increased PKC activity was stable 
to MonoQ chromatographic separation of cell ex- 
tracts. It is interesting to note that Begum et al. [48] 
have found that a sustained increase in [Ca2+] i to 
approx. 300 nM in rat adipocytes by membrane 
depolarization resulted in an inhibition of cytosolic 
and particulate protein phosphatase activity, which 
corresponded to increased phosphorylation states of 
two cellular proteins. Thus, it is possible that at a 
[Ca2+] o of 10 mM ([Ca 2+ ]i. 350 nM), dephosphoryla- 
tion of PKC is also inhibited. The inhibition of 
dephosphorylation f PKC and/or the stimulation of 
PKC phosphorylation presumably would have the 
effect of generating high levels of PKC activity in the 
absence of translocation. 
We cannot dismiss the possibility that the increase 
in cytosolic PKC activity at 10 mM Ca 2+ was due to 
the disruption of loosely-bound membrane PKC and 
its release into the cytosol during sample preparation. 
Bazzi et al. [49] has demonstrated the presence of a 
pool of membrane-inserted PKC in isolated mem- 
branes which can be distinguished from a second 
loosely-bound membrane-associated poolof PKC. By 
the addition of Ca2+-chelators (e.g. EGTA) to the 
homogenizing buffer, the latter is released into the 
cytosol fraction during cell disruption. In addition, Lu 
et al. [15] have reported an IL-2 stimulated activation 
of PKC which they claim to be translocation-inde- 
pendent and due to the activation of a loosely-bound 
membrane-associated pool of PKC. However, if the 
increase in cytosolic PKC activity in our study was 
due to the dissociation of loosely-bound PKC in the 
membrane by EGTA, then we would have expected 
to see an increase in the amount of PKC protein in 
the 10 mM [Ca 2+ ]o sample. Whatever the mechanism 
of PKC activation at 10 mM [Ca2+]o, the increases in 
both cytosolic and membrane-associated PKC activ- 
ity above control cannot be explained by transloca- 
tion. 
At 25 mM [Ca 2+]o, the observed ecrease in cy- 
tosolic PKC activity and slight increase in particulate 
PKC activity compared to control cultures may be 
indicative of a translocation of PKC from the cytosol 
to the membrane. This mechanism of PKC activation 
may be similar to that seen at 5 mM [Ca2+] o as 
steady state [Ca 2+ ]i values for these two groups were 
similar. However, the total PKC activity after expo- 
sure to 25 mM [Ca2+] owas less than that observed at 
control evels and considerably less than that seen at 
10 mM. Pre-treatment of cultures with an inhibitor of 
calpains I and II demonstrated higher PKC activity, 
indicating that PKC is proteolyzed by calpain, espe- 
cially at levels of [Ca2+] o above 25 mM. We did not 
evaluate the role of calpain at levels of [Ca 2+ ]o below 
25 mM. 
Analysis of [Ca2+]i at 25 and 50 mM revealed a
biphasic response. Immediately after exposure of cells 
to 25 or 50 mM Ca 2+, a transient increase in [Ca2+]i 
was seen followed by return to much lower steady 
state [Ca 2+ ]i values which were comparable in mag- 
nitude to [Ca2+] i obtained with lower [Ca2+] o. Since 
the Peak II histone H1 phosphotransferase ctivity in 
cultures incubated with [Ca2+] o lower than 25 mM 
was substantially less than that seen at 25 and 50 
mM, the increased activity of this kinase in the latter 
two [Ca2+]o is likely related to the Ca 2+ transient 
rather than to the steady state level of [Ca2+] i. We 
did not determine the magnitude of the Ca 2+ tran- 
sient necessary for the stimulation of the Peak II 
activity. Part of the Peak II activity appeared to be 
distinct from PKM as this activity was insensitive to 
inhibition by Ro 31-8220 or the PKC pseudosubstrate 
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inhibitor peptide. However, the ability of these in- 
hibitors to decrease PKC and PKM phosphorylation 
of histone H1 is incomplete, especially for PKM 
[33,50]. 
The decrease in total PKC activity at 25 mM and 
concomitant increases in cytosolic and particulate 
PKM protein support the notion that PKC was 
proteolytically cleaved to generate PKM, through the 
actions of calpain [16,17,34]. Calpain activation is 
known to be Ca2+-dependent with the two major 
isoforms of calpain differing in the threshold value of 
[Ca2+]i required for activation [see [51]]. Since a 
[Ca2+] i value of close to 400 nM did not generate 
much of an increase in PKM whereas a Ca 2 ÷ tran- 
sient to 600 nM did produce a considerable increase 
in PKM, we expect hat PKC activation by cleavage 
to PKM must occur at approx. 500-600 nM. The 
activation of calpains due to the transient [Ca2+]i 
increase may not have occurred with the slow rise to 
steady state [Ca2+] i seen with the lower [Ca2+] o
treatments. These results are in agreement with those 
of Melloni et al. [52], who showed that in neu- 
trophils, phorbol ester-stimulated PKC was converted 
to PKM at micromolar concentrations of Ca 2 +. Simi- 
lar observations have been made for platelets exposed 
to TPA [53] or to the Ca2+-ionophore A23187 [54]. 
PKM has also been detected in a neuroblastoma cell 
line following exposure to A23187 [55], which is 
consistent with the time course of PKM generation i
our experiments. Thus in NSC-19 cells, the conver- 
sion of PKC to the constitutively active fragment 
PKM at [Ca 2+ ]i greater than 600 nM may represent 
another mechanism for kinase regulation. 
Given that changes in [Ca2+]i have been impli- 
cated as critical steps in neuronal death, it is possible 
that [Ca 2+ ]i may exert its neurotoxic effects through 
stimulation of PKC, PKM or the unidentified kinase 
responsible for part of the Peak II phosphotransferase 
activity. The present study makes it clear that the 
consequences of elevation of [Ca2+] i can be very 
different depending on the amplitude of [Ca2+]i ob- 
tained, the rate of rise of [Ca 2+ ]~, and the presence of 
a Ca 2+ transient. Excitatory amino acid (EAA)-in- 
duced elevations of [Ca2+]i are typically rapid and 
associated with a prominent Ca 2+ transient, often 
followed by a normalization of [Ca2+] i for a period 
prior to cell death [2,3]. This pattern of [Ca2+]i 
change is similar to that seen in our experiments with 
exposure of cells to 25 and 50 mM [Ca2+]o, and thus 
would suggest hat EAA-induced [Ca2+]i increases 
might be associated with PKM production. The gen- 
eration of PKM, a constitutively active kinase, free 
from the regulatory constraints of PKC, could have 
major physiological consequences as this kinase 
would have access to the cytosol, and could phospho- 
rylate a larger group of substrates than the mem- 
brane-bound PKC [51,53,56]. 
Small increases in [Ca2+]i, which in the present 
study were not associated with Ca 2+ transients, may 
result in a pattern of kinase activation completely 
different from that seen with higher [Ca 2+ ]i. Observa- 
tions that low amplitude, long duration increases in 
[ Ca2+ ]i following application of metabolic inhibitors 
to cells in culture do not result in significant cell 
death [57] suggest that different cellular processes are 
activated compared to those which follow EAA ap- 
plication. It is possible that the different physiological 
consequences of EAA application versus metabolic 
inhibition are due to differences in the [Ca2+] i levels 
and Ca 2+ responses under the two conditions. [Ca 2+ ]i 
levels seen following metabolic inhibition in this cell 
line [21] are similar to those seen in the present 
experiments with exposure to [Ca2+] o less than 25 
mM. Thus, it is possible that the mechanism of PKC 
activation following metabolic inhibition is similar to 
exposure of NSC-19 neurons to low [Ca2+]o. This 
mechanism of PKC activation appears to be distinct 
from that observed when NSC-19 neurons are ex- 
posed to [Ca2+] o equal to or greater than 25 mM 
which may resemble the mechanism of PKC activa- 
tion following EAA application. It would not be 
surprising to see distinct physiological consequences 
under these different circumstances. 
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